What is the preferred preoperative antiseptic solution, 0.7% iodine (iodine) povacrylex in 74% isopropyl alcohol or 2% chlorhexidine (chlorhexidine) gluconate in 70% isopropyl alcohol, for surgical site infection prevention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preoperative Antiseptic Selection for Extremity Fracture Surgery

Either iodine povacrylex in 74% isopropyl alcohol or chlorhexidine gluconate in 70% isopropyl alcohol may be used for preoperative antisepsis in this patient, as there is no significant difference in the risk for surgical site infection, unplanned reoperation, or chemical burns based on the PREP-IT trial.

Evidence from the PREP-IT Trial

The PREP-IT trial, a recent large-scale cluster-randomized crossover trial conducted at 25 hospitals in the United States and Canada, provides the most definitive evidence for this clinical scenario 1. This trial specifically examined preoperative skin antisepsis in patients with extremity fractures, making it directly applicable to our patient with open fractures of the right pelvis, femur, and ankle.

Key findings from the PREP-IT trial:

  • For open fractures (like our patient has):

    • Surgical site infection occurred in 6.5% of patients in the iodine povacrylex group vs. 7.3% in the chlorhexidine gluconate group
    • No statistically significant difference was found (odds ratio 0.86; 95% CI 0.58-1.27; p=0.45)
    • Frequencies of unplanned reoperation and serious adverse events were similar between groups
  • For closed fractures (included for completeness):

    • A small but statistically significant difference favoring iodine povacrylex was observed (2.4% vs. 3.3% infection rate; p=0.049)

Guidelines and Additional Evidence

Current guidelines provide somewhat conflicting recommendations:

  • The 2023 ERAS Society guidelines for liver surgery recommend chlorhexidine-alcoholic solution, noting it is associated with lower surgical site infection rates compared to povidone-iodine 2.

  • A 2020 guideline for dialysis unit infection prevention recommends alcohol-based chlorhexidine (>0.5% solution) for disinfection, with povidone iodine or 70% alcohol as acceptable alternatives 2.

  • The American Society for Microbiology's 2024 evidence-based guidelines showed that chlorhexidine was associated with a 56.5% reduction in blood culture contamination rates compared to other antiseptics 2.

Considerations for This Patient

For this specific patient with open fractures:

  1. Type of surgery: The patient has open fractures requiring surgical fixation, which matches the open fracture population in the PREP-IT trial.

  2. Timing: The patient has already undergone initial debridement and is now scheduled for definitive fixation, similar to the PREP-IT trial protocol.

  3. Risk factors: The patient has no significant past medical history that would influence antiseptic selection.

Potential Pitfalls and Caveats

  • Chemical burns: Neither antiseptic solution has been shown to have a higher risk of chemical burns in the PREP-IT trial.

  • Antimicrobial resistance: Long-term concerns about antimicrobial resistance exist for both agents but should not influence immediate clinical decision-making.

  • Cost considerations: While cost may differ between products, this should not be the primary consideration when infection prevention is the goal.

Conclusion

Based on the most recent and highest-quality evidence from the PREP-IT trial, either 0.7% iodine povacrylex in 74% isopropyl alcohol or 2% chlorhexidine gluconate in 70% isopropyl alcohol is an appropriate choice for this patient with open fractures. The trial showed no significant difference in infection rates, reoperation rates, or adverse events between these two antiseptic solutions for open fractures.

References

Research

Skin Antisepsis before Surgical Fixation of Extremity Fractures.

The New England journal of medicine, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the preferred antiseptic solution for preoperative antisepsis, 0.7% iodine (iodine) povacrylex in 74% isopropyl alcohol or 2% chlorhexidine (chlorhexidine) gluconate in 70% isopropyl alcohol, for surgical site infection prevention?
What is the preferred preoperative skin antisepsis agent for a patient with hypertension, type 2 diabetes mellitus, and colon adenocarcinoma undergoing colon resection to prevent surgical site infection (SSI)?
What was the rationale for the PREP-IT study comparing isopropyl alcohol-based solutions containing iodine povacrylex with chlorhexidine gluconate for preoperative antisepsis in surgical procedures to repair extremity fractures?
What was the rationale for the study by Widmer and colleagues comparing alcohol-based solutions containing povidone iodine (Polyvinylpyrrolidone-Iodine) or chlorhexidine gluconate (Chlorhexidine Gluconate) as preoperative antisepsis for cardiac or abdominal surgery?
What is the preferred antiseptic for skin preparation before surgery, chlorhexidine or betadine (povidone-iodine)?
What are the benefits of adding memantine to donepezil (Aricept) in patients with Alzheimer's disease?
What are the management options for a 90-year-old patient with a Mini-Mental State Examination (MMSE) score of 20/30?
What is the pathophysiology of alcoholic ketoacidosis and alcohol withdrawal and the rationale for their treatment?
What is the most appropriate oral voriconazole (Voriconazole) dosing regimen for a patient with a complicated intra-abdominal infection caused by echinocandin- and fluconazole-resistant Candida glabrata, transitioning from intravenous (IV) to oral therapy?
What is the best treatment for Irritable Bowel Syndrome (IBS)?
What is the best course of action for a patient with a low posaconazole trough concentration of 0.4 mg/L after hematopoietic cell transplant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.